Company
Omzo
Omzo publishes compounded semaglutide and compounded tirzepatide, from $179 to $279 a month.
- 2 programs
- 2 molecules
- 2 readings
Read from omzo.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to Omzo
We earn nothing from this link. Omzo has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · Semaglutide, starting price
first month, including the required fees on record · Tirzepatide, starting price
Terms
| States | All 50 states |
|---|
Not yet checked: pharmacy, membership and consultation fee.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. The /weight-loss page is a JavaScript-rendered shell with no visible pricing text; the only GLP-1 prices found were the homepage's 'Starting at $179' (semaglutide) and 'Starting at $279' (tirzepatide) tiles, with no unit stated for the figure (assumed monthly, the site's evident convention). Omzo's fee statement says medication cost is bundled into the fees it collects ('Medication costs are included in the fees collected by Omzo'), consistent with these being real program prices rather than an excluded-medication membership. The state-coverage sentence is a stronger, unambiguous '50 states' claim than a vague 'nationwide' phrase, so it was recorded as all-50 rather than not-found.
Before you act
Cite this
Treatment Registry. (2026). Omzo: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/omzo